Naurex Raises $38M
Posted on: December 17, 2012 by StaffNo Comments »
Naurex Inc., a clinical-stage company focused on psychiatry and neurology, raised $38 million in Series B financing led by new investor Baxter Ventures. New investor Savitr Capital also participated in the financing, along with existing investors Adams Street Partners, Latterell Venture Partners, Genesys Capital, PathoCapital, Druid Bioventures, and Northwestern University, the company announced. Corporate investors Lundbeck, Takeda Ventures and Shire also contributed to the round. Naurex is based in Evanston, Illinois.




